Immune biology of acute myeloid leukemia: Implications for immunotherapy

Sophia Khaldoyanidi; Dirk Nagorsen; Anthony Stein; Gerrit Ossenkoppele; Marion Subklewe

doi:https://doi.org/10.1200/JCO.20.00475

Immune biology of acute myeloid leukemia: Implications for immunotherapy

Sophia Khaldoyanidi, Dirk Nagorsen, Anthony Stein, Gerrit Ossenkoppele, Marion Subklewe

Research output: Contribution to journal › Review article › Academic › peer-review

31 Citations (Scopus)

Original language	English
Pages (from-to)	419-432
Number of pages	14
Journal	Journal of clinical oncology
Volume	39
Issue number	5
DOIs	https://doi.org/10.1200/JCO.20.00475
Publication status	Published - 1 Jan 2021

Access to Document

https://doi.org/10.1200/JCO.20.00475

Cite this

@article{797d4c31d8f949cb86e41c1603ef4333,

title = "Immune biology of acute myeloid leukemia: Implications for immunotherapy",

author = "Sophia Khaldoyanidi and Dirk Nagorsen and Anthony Stein and Gerrit Ossenkoppele and Marion Subklewe",

note = "Funding Information: Medical writing assistance was funded by Amgen. Funding Information: Medical writing assistance was provided by Andrew Gomes, PhD, of BlueMomentum, an Ashfield Company, part of UDG Healthcare, and funded by Amgen. Editorial support was provided by Indira Venkatasubramanian, PhD, Amgen. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = jan,

day = "1",

doi = "https://doi.org/10.1200/JCO.20.00475",

language = "English",

volume = "39",

pages = "419--432",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "5",

}

TY - JOUR

T1 - Immune biology of acute myeloid leukemia: Implications for immunotherapy

AU - Khaldoyanidi, Sophia

AU - Nagorsen, Dirk

AU - Stein, Anthony

AU - Ossenkoppele, Gerrit

AU - Subklewe, Marion

N1 - Funding Information: Medical writing assistance was funded by Amgen. Funding Information: Medical writing assistance was provided by Andrew Gomes, PhD, of BlueMomentum, an Ashfield Company, part of UDG Healthcare, and funded by Amgen. Editorial support was provided by Indira Venkatasubramanian, PhD, Amgen. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/1/1

Y1 - 2021/1/1

UR - http://www.scopus.com/inward/record.url?scp=85102025374&partnerID=8YFLogxK

U2 - https://doi.org/10.1200/JCO.20.00475

DO - https://doi.org/10.1200/JCO.20.00475

M3 - Review article

C2 - 33434043

SN - 0732-183X

VL - 39

SP - 419

EP - 432

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 5

ER -

Immune biology of acute myeloid leukemia: Implications for immunotherapy

Access to Document

Other files and links

Cite this